Domain > www.kanjinti.eu

Welcome! Right click nodes and scroll the mouse to navigate the graph.

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2025-01-06	20.50.2.31 (ClassC)

HTTP/1.1 200 OKContent-Length: 49371Content-Type: text/html; charsetutf-8Date: Thu, 26 Dec 2024 18:13:15 GMTCache-Control: no-cache, no-store,no-cache, no-store, must-revalidate, pre-check0, post-chec

!DOCTYPE html>html langen>head prefixog: http://ogp.me/ns# fb: http://ogp.me/ns/fb# website: http://ogp.me/ns/website#>            !-- Google Tag Manager -->    script typetext/plain data-cookieconsentpreferences, statistics, marketing>        (function(w, d, s, l, i) {        wl  wl || ;        wl.push({        gtm.start:        new Date().getTime(),        event: gtm.js        });        var f  d.getElementsByTagName(s)0,        j  d.createElement(s),        dl  l ! dataLayer ? &l + l : ;        j.async  true;        j.src         https://www.googletagmanager.com/gtm.js?id + i + dl;        f.parentNode.insertBefore(j, f);        })(window, document, script, dataLayer, GTM-KJ27N7Q);        /script>        !-- End Google Tag Manager -->              meta charsetutf-8>    meta http-equivX-UA-Compatible contentIEedge>    meta nameformat-detection contenttelephoneno />    meta nameversion content1.0.0.0 />    meta namedatetime contentJanuary 30, 2023 (Monday); 05:04:00 />    meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno>    add nameCache-Control valueno-cache />    add namePragma valueno-cache />    add nameExpires value-1 />    script srchttps://cdnjs.cloudflare.com/ajax/libs/jquery/3.2.1/jquery.min.js typetext/javascript>/script>            title>Kanjinti (trastuzumab) | Amgen Biosimilars | Amgen/title>        meta namedescription contentKanjinti is a cancer medicine used for treatment of HER2 positive breast and metastatic gastric cancer patients. This website is meant for EU Healthcare Professionals only. >        link relcanonical hrefhttps://www.kanjinti.eu/ />meta namegoogle-site-verification contentUKvJ0YO2SiN9KD9slLEePWGpDWH2jqIzCfErEgzlsiQ />meta propertyog:title contentKanjinti (trastuzumab) | Amgen Biosimilars | Amgen/>meta propertyog:description contentKanjinti is a cancer medicine used for treatment of HER2 positive breast and metastatic gastric cancer patients. This website is meant for EU Healthcare Professionals only. />meta propertyog:type contentwebsite/>meta property

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.kanjinti.eu

Is this malicious?

DNS Resolutions

Port 443